Abstract
### Inhibiting SARS-CoV-2 with a Soluble ACE2 Variant Use of a soluble angiotensin-converting enzyme 2 (ACE2) protein has been proposed as a way to inhibit binding of the S spike of SARS-CoV-2 to the full-length membrane-bound ACE2 receptor. Wysocki et al. developed a newly bioengineered soluble
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Society of Nephrology : JASN
Paper Title
Journal
Date
